The prevalence of diabetes was 15.8 percent among U.S. adults during August 2021 to August 2023, according to a November data brief published by the National Ce ...

"We have seen an alarming rise in diabetes over the past three decades, which reflects the increase in obesity, compounded by the impacts of the marketing of unhealthy food, a lack of physical ...

Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate ...

The past doesn't predict the future ... is a hot growth stock to buy, as investors are bullish on its prospects in the weight loss market. The company has an incredibly promising product in ...

Diabetes rates have more than doubled globally in the past three decades, with over 800 million people now living with the ...

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

Future of Healthcategory Eli Lilly's weight-loss drug helps nearly 99% of patients remain diabetes-free November 13, 2024 ...

The global dialysis equipment market is on a strong growth trajectory, with projected sales expected to increase from USD ...

Analyst Michael Nedelcovych from TD Cowen maintained a Buy rating on Novo Nordisk (NVO – Research Report) and keeping the price target at ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

We recently published a list of 10 Best Stocks to Buy According to Billionaire Ken Fisher. In this article, we are going to ...

During quarterly earnings calls across the medtech industry, a recurring question has been on investors’ minds: If ...